Israeli company HIL Applied Medical, which develops laser-accelerated proton beams for medical purposes, has acquired US company Nanolabz. “The merger with Nanolabz makes it possible to combine the two companies’ patents and development teams, which complement each other, enabling us to accelerate our development,” says HIL Applied Medical CEO Sagi Brink-Danan. Following the merger, Nanolabz’s name will be changed to HIL US. The development center in the US will continue operating side by side with the Israeli development center, which will manage it.

Read more on Globes